Arsenic trioxide (ATO) has been demonstrated to induce apoptosis in retinoblastoma cells, however, mechanisms responsible for this phenomenon are not fully understood. In the present study, we determined whether ATO induced apoptosis by abnormal expression of microRNA. In an apoptosis model of retinoblastoma cells subjected to 4 μM ATO for 72 hours, we found 14 miRNAs changed more than 2-fold by using miRNA microarray analysis. Most of these aberrantly expressed miRNAs were confirmed by quantitative RT-PCR. MiR-376a, a significantly down-regulated miRNA, was selected for further study. The overexpression of miR-376a resulting from miR-376a mimic transfection significantly inhibited ATO-induced apoptosis. By contrast, miR-376a deficiency resulting from miR-376a inhibitor transfection aggravated ATO-induced apoptosis. Using bioinformatic algorithms, caspase-3, a key apoptosis executioner, was predicted as a putative target of miR-376a. The quantitative RT-PCR showed no effects of miR-376a mimic or inhibitor on caspase-3 mRNA level. However, the amount of caspase-3 proteins was reduced by miR-376a mimic, whereas increased by miR-376a inhibitor. Furthermore, the luciferase reporter assay confirmed caspase-3 to be a target of miR-376a, and the apoptosis caused by miR-376a inhibitor were abolished by a caspase-3 inhibitor. These results suggest that ATO -induced apoptosis in retinoblastoma cells is part mediated by decreasing expression of miR-376a, which subsequently increased caspase-3 expression.
Retinoblastoma is the third most common form of cancer in infants, and metastatic retinoblastoma is lethal in approximately 90% of cases. Early detection and aggressive therapy has resulted in a 95% probability of survival for retinoblastoma patients in the United States [1] . However, the United States represents only 3-4% of the retinoblastoma cases worldwide. The majority of children diagnosed with retinoblastoma each year live in developing countries where the probability of survival is closer to 50%. This difference in survival rates reflects poor early detection rates and limited resources for the aggressive therapy necessary to treat retinoblastoma and manage the side effects associated with broad-spectrum systemic chemotherapy in young children. In order to have the most significant impact on retinoblastoma treatment, current efforts have been focused on reducing the side effects associated with systemic broad-spectrum chemotherapy.
Arsenic trioxide (ATO) is presently the most active single agent in the treatment of acute promyelocytic leukemia (APL) [2] . ATO acts by targeting multiple pathways in APL leading to apoptosis and myeloid differentiation. It induces complete remission without myelosuppression and causes only few adverse effects. Although its mode of action is still not fully understood, ATO is known to induce cell apoptosis via generation of reactive oxygen species and activation of caspases. Several reports have indicated that ATO acts principally by inducing cell apoptosis not only in APL, but in a variety of non-APL cells including myeloma cells, chronic myeloid leukemia cells and cells of immune origin, including B or T lymphocytes, macrophages and, more recently, neuroblastoma [3, 4] . Retinoblastoma shares phenotypic similarities with neuroblastoma, which has been proved by morphologic, cytogenetic, immunohistochemical, biochemical, and in vitro studies [5, 6] . Furthermore, it has been reported that high dose ATO had antitumor activity for retinoblastoma by promoting apoptosis [7] , but its mechanism is still not very clear.
Given that microRNAs (miRNAs) are important in appropriate cellular function for development, tissue maintenance, and physiology, it is not surprising that the deregulation of miRNAs function is associated with disease. In several human cancer types, miRNAs have been implicated as oncogenes and tumor suppressor genes [8, 9] . Experiments have identified miRNAs tumor suppressors such as miR-15a, 16-1, 17-5p, 143, 145, and let-7 [9] . In human retinoblastoma, differential let-7b miRNA expression and mRNA expression of let-7b targets has been observed [10] , so it is very interesting to investigate whether ATO promote apoptosis of retinoblastoma cells by regulating the expression of miRNAs.
Materials and methods
Cell lines and culture. Human retinoblastoma cell line HXO-RB44 was maintained in RPMI 1640 media, supplemented with 10% fetal bovine serum (Gibco BRL, Rockville, MD) and 1% antibiotic-antimycotic solution (Invitrogen, Carlsbad, CA) at 37°C in a moist atmosphere of 95% air and 5% CO 2 . The medium was changed every third day. Cultured tumor cells were observed daily under a phase-contrast microscope.
Analysis of cell apoptosis. In the AV/PI staining method, PI distinguishes viable from dead cells based on its exclusion by viable cells. AV is a common marker for apoptosis due to their high affinity for phosphatidylserine, which is translocated from the inner to the outer leaflet of the plasma membrane in early apoptosis [11, 12] . The cells were dual-stained with AV and PI, and then analyzed by flow cytometry.
MiRNA-microarray. Total RNA of cells was isolated by using TRIzol reagent, and reverse transcribed according to the manufacturer's instructions (Fermentas, in CA). MiRNA expression profiling was determined by miRNA-microarray analysis (LC Sciences Inc).
Real-time RT-PCR. Real-time RT-PCR was performed to verify the levels of miRNAs. 1μg of total RNA extracted with Trizol (Invitrogen, Shanghai, China) was reverse-transcribed using M-MLV reverse transcriptase with oligo-dT for mRNAs and a special stem-loop primer for a miRNA (Table 1) . Realtime quantitative PCR was performed on a Rotor-Gene 3,000 real-time DNA detection system (Corbett Research, Sydney, Australia) using SYBR Green (Qiagen, Shanghai, China) and the primers listed in Table 2 . U6 is spliceosome RNA, the abundance of which is similar to small molecular RNA, and used as miRNA internal reference. GAPDH is a house-keeping gene, and used as a common gene as internal reference of caspase-3.
MiRNA transfection experiments. For transfection experiments, retinoblastoma cells were seeded at a density of 2* 10 4 cells/cm 2 in serum-free DMEM, with the addition of transfection agent and RNAs. The mimic of miR-376a was a duplex RNA, in which the sense sequence was the same as miR-376a. The inhibitor of miR-376a was a single RNA sequence exactly complementary to miR-376a. Mock transfection (transfection without RNA) and non-targeting negative control sequences were used as controls.
Construction of luciferase reporter plasmid and analysis of luciferase activity. To examine whether miR-376a regulates the expression of caspase-3, a predicted target of miR-376a, the dual luciferase psiCheck2 reporter plasmid (Promega, Madison, WI, USA) was used to generate the reporter plasmid harboring caspase-3 3'-UTR. Briefly, a 307-bp fragment of caspase-3 3'-UTR containing the putative miR-376a binding site was amplified from genomic DNA by PCR, using Xho1 and Not1 primers (left Xho1 primer: ctcgagCGGAG- Table 1 . Primers for reverse-transcription of miRNAs
MicroRNA
Primers for reverse-transcription (5'-3') hsa-miR-376a gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtgg ACGTGG hsa-miR-491-3p gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggGTAGAAG hsa-miR-220b gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtgg AAGTGT hsa-miR-524-5p gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggGAGAAAG let7b gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggAACCACA hsa-miR-125a-3p gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtGGCTCCCA hsa-miR-943 gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggCTGGAGG hsa-miR-649 gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggGACTCTTG hsa-miR-890 gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggCAACTG hsa-miR-628-3p gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggTCGACTG hsa-miR-425 gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggTCAACG hsa-miR-129-5p gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggGCAAGC hsa-miR-34a gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtgGACAACC hsa-miR-181b gtcgtatccagtgcagggtccgaggtattcgcactggatacgacacgtggACCCACCG CAGAGCCATGGGCACGTC TTCAG, right Not1 primer: gcggccgcCCTATTGCTGGATGCTTTCCAAGTCCC). The PCR product was digested with Xho1 and Not1, followed by insertion into the multiple cloning region located at the 3'-UTR of the synthetic Renilla luciferase gene within the psiCheck2 plasmid. The psiCheck2 plasmid also contains a synthetic firefly luciferase gene that serves as the transfection control. The retinoblastoma cells were co-transfected with the psiCheck2 vector containing caspase-3 3'-UTR and miR-376a mimic using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), and the co-transfection with non-targeting negative control RNA was performed as control. The cells were harvested 24 h after transfection, and luciferase activity was measured with a dual luciferase reporter assay kit (Promega, Madison, WI, USA) on a luminometer (Lumat LB9507). Western blot analysis. The retinoblastoma cells were lysed with RIPA buffer (Beyotime, Jiangsu, China), sonicated on ice, and protein concentration was determined using the bicinchoninic acid kit (Beyotime, Jiangsu, China). 20 μg of total protein were electrophoresed on a 10% (w/v) SDS-PAGE gel, transferred onto nitrocellulose membrane and blocked with 5% (w/v) non-fat dried milk. Membranes were probed with the caspase-3 primary antibody (1:200), followed by the peroxidase-conjugated secondary antibody. Protein signal was visualized by chemiluminescence reagents under a GeneGnome Bio Imaging System (Syngene, MD,USA). The amount of full-length and cleaved caspase-3 was quantified by densitometry and normalized to GAPDH, an internal standard.
Statistical analysis. Statistical analyses were carried out using Student's t test between two groups or ANOVA followed by post hoc comparisons among three or more groups. All data provided here are mean ± SD. P < 0.05 was considered significant.
Results

Effect of ATO on induction of apoptosis in retinoblastoma cells.
Retinoblastoma cells were treated with ATO for 72 hours, and apoptosis was detected by AV/PI dual staining. As shown in Figure. rate in ATO treated groups at the five concentrations were 6.0 ± 0.7%, 11.6 ± 1.3%, 29.6 ± 2.4%, 54.9 ± 5.3%, 60.3 ± 5.4%, respectively. The apoptotic rate of higher concentration groups (1-8 μM) were all significantly higher than that of control group (4.4 ± 0.5%, P<0.01). 4 μM ATO induced obvious apoptosis and the dose is not too high, so we used 4 μM ATO in the further study.
MiRNA expression profiles in retinoblastoma cells treated with ATO.
MiRNA microarray analysis showed that 14 miRNAs were regulated by at least 2-fold in retinoblastoma cells treated with 4 μM ATO, compared to the control group (Table 3) . Among them, miR-376a, -491-3p, -220b, -524-5p and -let7b were down-regulated, whereas miR-125a-3p, -943, -649, -890, -628-3p, -425, -129-5p, -34a, and -181b were upregulated. The abovementioned miRNAs aberrantly expressed in retinoblastoma cells treated with 4 μM ATO were mostly verified by real-time RT-PCR (Table 1) . MiR-376a was selected for further functional studies because of its remarkable change in response to ATO and bioinformatic prediction of potential target genes associated with apoptosis.
3. MiR-376a expression was regulated by its mimic and inhibitor. In cultured retinoblastoma cells, transfection of miR-376a mimic or inhibitor with the aid of transfection agents significantly increased or decreased the level of miR376a ( Figure. 2). The dose of 50 nM was identified to be optimal for both the mimic and inhibitor of miR-376a during preliminary experiments. As shown in Figure. 2, neither mock nor negative control RNA transfection affected miR-376a expression in cultures. 50 nM miR-376a mimic and inhibitor up-or down-regulated miR-376a by 14.5 ± 2.8 and 3.0 ± 0.4-fold of blank (both P<0.01), respectively. Figure. 3, the rate of apoptosis in normal cultured retinoblastoma cells was approximately 5%. Mock, control RNA or miR-376a mimic transfection did not alter baseline apoptosis. By contrast, the miR-376a inhibitor resulted in a much higher rate of apoptosis (31.2 ± 5.4%, P<0.01). We further investigated the effects of miR-376a on ATO-induced apoptosis in retinoblastoma cells. As shown in Figure. 4, miR-376a mimic decreased ATO-induced apoptosis. By contrast, miR-376a inhibitor further aggravated ATO-induced apoptosis.
Effect of miR-376a on apoptosis in retinoblastoma cells. As shown in
5. Caspase-3 is a target of miR-376a. To explore the molecular mechanism, we searched for potential targets of miR-376a using bioinformatic algorithms such as MiRanda (August 2010 Release, http://www.microrna.org), Pictar Caspase-3, a critical executioner of apoptosis, was predicted as a putative target of miR-376a. One miR-376a-binding site was identified within the 3'-UTR of caspase-3 mRNA (Fig. 5A) .
To examine whether miR-376a regulates caspase-3 expression, we generated a luciferase reporter encoding caspase-3 3'-UTR that contains miR-376a binding sites. This reporter was co-transfected with miR-376a mimic into retinoblastoma cells, and the luciferase activity assay was performed 24 h after transfection. Compared with the negative control RNA, the miR-376a mimic significantly suppressed the activity of the luciferase reporter fused with caspase-3 3'-UTR by 35% (Figure . 5B), suggesting the inhibition of miR-376a on caspase-3 expression through its 3'-UTR. Additionally, we determined both the mRNA and protein levels of caspase-3. As shown in Figure. 5C-E, the mRNA and protein levels of caspase-3 were exclusively increased by 4 μM ATO. No changes of caspase-3 mRNA were detected in normal solution or ATO-treated cells transfected with the miR-376a mimic or inhibitor. However, remarkable increases of caspase-3 proteins were observed in cells receiving the miR-376a inhibitor ( Figure. 5D and E) . Furthermore, miR-376a mimic significantly decreased caspase-3 proteins. These results indicate that miR-376a inhibits the synthesis of caspase-3 proteins, likely through post-transcriptional mechanisms. Furthermore, as shown in Figure 3 and Figure 4 , the increased apoptosis of retinoblastoma cells caused by the miR-376a inhibitor was abolished by 10 μM Ac-DEVD-CHO, a caspase-3 inhibitor, suggesting that miR376a involved in ATO-induced apoptosis in retinoblastoma cells by caspase-3.
Discussion
In the present study, we demonstrated that ATO induced apoptosis in retinoblastoma cells by decreasing expression of miR-376a, in association with increased expression of caspase-3, which is a target of miR-376a.
The accumulating evidences indicated that ATO could regulate many biological functions such as cell proliferation and apoptosis in retinoblastoma cells [7] . Apoptosis is an important mode of cell death that occurs in response to a variety of agents including ionizing radiation or anticancer chemotherapeutic drugs [13] . Several lines of evidence suggest that interleukin-1-converting enzyme (ICE)/caspase family plays a crucial role in apoptosis [14, 15] . Especially, caspase-3 has been shown to be a key component of the apoptotic machinery.
MiRNAs are approximately 22-nucleotide endogenous RNAs that exert profound biological effects. MiRNAs are usually post-transcriptional regulators that bind to partly complementary sequences in the 3'-UTR of target mRNAs, resulting in translational repression [16, 17] . It is estimated that over 1000 miRNAs are encoded in the human genome, and they target approximately 60% of mammalian genes [18] . Accumulating evidence has shown that miRNAs can function as oncogenes or tumor suppressors involved in cancer development, including tumor metastasis and proliferation [17, 19] .
In the present study, the miRNA microarray analysis identified 14 miRNAs in the retinoblastoma cells treated by ATO changing more than 2-fold compared to the control group. Among them, the up-regulation of miR-125a-3p, -943, -649, -890, -628-3p, -425, -129-5p and -181b, and the down-regulation of miR-376a, -491-3p, -220b and -524-5p were confirmed by real-time PCR. A major finding of the present study is that low expression of miR-376a significantly promoted apoptosis of retinoblastoma cells by increasing caspase-3 protein levels. Based on bioinformatic algorithms, many genes were included as potential targets of miR-376a. Strikingly, caspase-3 is one of them. The luciferase reporter assay in this study confirmed caspase-3 to be a target of miR-376a. Caspase-3 is a well-established executioner of apoptosis. In the present study, we observed that miR-376a overexpression significantly reduced protein levels of caspase-3, but did not affect mRNA levels of caspase-3, suggesting that miR-376a inhibits caspase-3 expression at the level of postatranscription, which is one of the major patterns of miRNA action [20] . Recently, Su et al reported there was functional complementation between transcriptional methylation regulation and post-transcriptional microRNA regulation in the human genome [21] , so DNA methylation may be another mechanism besides post-transcriptional.
In summary, our study is the first to show the ATO induced apoptosis in retinoblastoma cells by unnormal expression of miRNAs. Moreover, we identified the regulatory effects of miR-376a on caspase-3 expression, indicating a potential role of miR-376a in other disorders associated with apoptosis.
